Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-May-24 7:02 PM View:  | Amgen Inc. (AMGN) | 07-May-24 | Grant | 3,529 | -- | -- | 7% 49.15K to 52.67K | |
| 07-May-24 8:32 PM View: | Amgen Inc. (AMGN) | 05-May-24 | Payment of Exercise | 665 | $311.29 | $207,008.00 | (1%) 49.81K to 49.15K | |
| 03-May-24 7:18 PM View: | Amgen Inc. (AMGN) | 02-May-24 | Payment of Exercise | 758 | $277.37 | $210,246.00 | (1%) 50.57K to 49.81K | |
| 01-May-24 7:51 PM View: | Amgen Inc. (AMGN) | 30-Apr-24 | Payment of Exercise | 753 | $276.38 | $208,114.00 | (1%) 51.32K to 50.57K | |
| 20-Mar-24 8:00 PM View: | Amgen Inc. (AMGN) | 18-Mar-24 | Payment of Exercise | 6,461 | $268.87 | $1,737,170.00 | (11%) 57.78K to 51.32K | |
| 08-Mar-24 5:25 PM View: | Amgen Inc. (AMGN) | 06-Mar-24 | Grant | 12,924 | -- | -- | 29% 44.65K to 57.57K | |
| 11-Aug-23 6:13 PM View: | Amgen Inc. (AMGN) | 10-Aug-23 | Private Sale | 9,558 | $262.43 | $2,508,310.00 | (18%) 53.87K to 44.31K | |
| 09-May-23 7:13 PM View: | Amgen Inc. (AMGN) | 05-May-23 | Payment of Exercise | 623 | $231.89 | $144,467.00 | (1%) 54.49K to 53.87K | < 1% |
| 04-May-23 10:00 PM View: | Amgen Inc. (AMGN) | 03-May-23 | Payment of Exercise | 859 | $235.97 | $202,698.00 | (2%) 55.35K to 54.49K | |
| 04-May-23 10:00 PM View: | Amgen Inc. (AMGN) | 02-May-23 | Grant | 4,237 | -- | -- | 8% 51.11K to 55.35K | |
| 02-May-23 10:00 PM View: | Amgen Inc. (AMGN) | 30-Apr-23 | Payment of Exercise | 728 | $239.74 | $174,531.00 | (1%) 51.84K to 51.11K | 4% |
| 20-Mar-23 7:05 PM View: | Amgen Inc. (AMGN) | 17-Mar-23 | Payment of Exercise | 3,978 | $234.57 | $933,120.00 | (7%) 55.82K to 51.84K | 2% |
| 08-Mar-23 7:18 PM View: | Amgen Inc. (AMGN) | 06-Mar-23 | Grant | 7,947 | -- | -- | 17% 47.67K to 55.62K | |
| 23-Aug-22 5:37 PM View: | Amgen Inc. (AMGN) | 22-Aug-22 | Gift | 400 | -- | -- | (< 1%) 47.88K to 47.48K | |
| 09-May-22 7:02 PM View: | Amgen Inc. (AMGN) | 05-May-22 | Payment of Exercise | 603 | $236.10 | $142,368.00 | (1%) 48.39K to 47.78K | 2% |
| 04-May-22 7:48 PM View: | Amgen Inc. (AMGN) | 03-May-22 | Payment of Exercise | 808 | $230.92 | $186,583.00 | (2%) 49.2K to 48.39K | |
| 04-May-22 7:48 PM View: | Amgen Inc. (AMGN) | 02-May-22 | Grant | 4,330 | -- | -- | 10% 44.87K to 49.2K | |
| 22-Mar-22 5:38 PM View: | Amgen Inc. (AMGN) | 18-Mar-22 | Payment of Exercise | 4,995 | $235.86 | $1,178,120.00 | (10%) 49.86K to 44.87K | 2% |
| 03-Mar-22 7:25 PM View: | Amgen Inc. (AMGN) | 01-Mar-22 | Grant | 9,989 | -- | -- | 25% 39.69K to 49.68K | |
| 03-Nov-21 7:26 PM View: | Amgen Inc. (AMGN) | 02-Nov-21 | Payment of Exercise | 5,585 | $209.79 | $1,171,680.00 | (12%) 45.19K to 39.6K | (2%) |
| 04-May-21 7:12 PM View: | Amgen Inc. (AMGN) | 03-May-21 | Payment of Exercise | 782 | $239.64 | $187,398.00 | (2%) 45.63K to 44.85K | |
| 04-May-21 7:12 PM View: | Amgen Inc. (AMGN) | 30-Apr-21 | Grant | 4,172 | -- | -- | 10% 41.46K to 45.63K | |
| 22-Mar-21 6:24 PM View: | Amgen Inc. (AMGN) | 19-Mar-21 | Payment of Exercise | 8,989 | $244.42 | $2,197,090.00 | (18%) 50.45K to 41.46K | (< 1%) |
| 04-Mar-21 8:22 PM View: | Amgen Inc. (AMGN) | 02-Mar-21 | Grant | 17,989 | -- | -- | 56% 32.17K to 50.16K | |
| 04-Nov-20 7:00 PM View: | Amgen Inc. (AMGN) | 02-Nov-20 | Payment of Exercise | 6,269 | $216.94 | $1,360,000.00 | (16%) 38.3K to 32.04K | (11%) |
| 07-May-20 8:55 PM View: | Amgen Inc. (AMGN) | 05-May-20 | Grant | 3,469 | -- | -- | 10% 34.4K to 37.87K | |
| 05-Nov-19 6:50 PM View: | Amgen Inc. (AMGN) | 02-Nov-19 | Payment of Exercise | 5,812 | $217.95 | $1,266,730.00 | (15%) 39.84K to 34.02K | (7%) |
| 07-May-19 6:55 PM View: | Amgen Inc. (AMGN) | 03-May-19 | Grant | 4,511 | -- | -- | 13% 34.73K to 39.24K | |
| 06-Nov-18 6:11 PM View: | Amgen Inc. (AMGN) | 02-Nov-18 | Grant | 34,213 | -- | -- | 100% 0 to 34.21K | |
| 03-Aug-18 5:05 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Aug-18 | Payment of Exercise | 744 | $59.62 | $44,357.30 | (1%) 50.17K to 49.42K | < 1% |
| 03-Aug-18 5:05 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Aug-18 | Option Exercise | 1,510 | -- | -- | 3% 48.66K to 50.17K | |
| 13-Mar-18 4:55 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-18 | Payment of Exercise | 20,082 | $67.92 | $1,363,970.00 | (29%) 68.74K to 48.66K | 14% |
| 13-Mar-18 4:55 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-18 | Acquisition (other) | 1,537 | -- | -- | 5% 27.97K to 29.5K | |
| 13-Mar-18 4:55 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-18 | Option Exercise | 39,235 | -- | -- | 133% 29.5K to 68.74K | |
| 03-Aug-17 5:07 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Aug-17 | Payment of Exercise | 783 | $56.10 | $43,926.30 | (3%) 28.75K to 27.97K | (3%) |
| 03-Aug-17 5:07 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Aug-17 | Option Exercise | 1,510 | -- | -- | 6% 27.24K to 28.75K | |
| 14-Mar-17 8:31 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-17 | Payment of Exercise | 12,817 | $58.32 | $747,487.00 | (31%) 40.82K to 28.0K | 2% |
| 14-Mar-17 8:31 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-17 | Acquisition (other) | 764 | -- | -- | 5% 14.47K to 15.23K | |
| 14-Mar-17 8:31 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-17 | Disposition (other) | 764 | -- | -- | (3%) 28.0K to 27.24K | |
| 14-Mar-17 8:31 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-17 | Option Exercise | 25,592 | -- | -- | 168% 15.23K to 40.82K | |
| 03-Aug-16 4:56 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Aug-16 | Payment of Exercise | 784 | $76.19 | $59,733.00 | (5%) 15.25K to 14.47K | 26% |
| 03-Aug-16 4:56 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Aug-16 | Option Exercise | 1,511 | -- | -- | 11% 13.74K to 15.25K | |
| 06-Jul-16 5:58 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Jul-16 | Payment of Exercise | 1,211 | $73.78 | $89,347.60 | (8%) 14.95K to 13.74K | 24% |
| 06-Jul-16 5:58 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Jul-16 | Option Exercise | 2,335 | -- | -- | 19% 12.62K to 14.95K | |
| 14-Mar-16 9:41 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-16 | Payment of Exercise | 10,675 | $64.94 | $693,234.00 | (46%) 23.33K to 12.65K | 15% |
| 14-Mar-16 9:41 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-16 | Acquisition (other) | 1,313 | -- | -- | 49% 2.71K to 4.02K | |
| 14-Mar-16 9:41 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-16 | Disposition (other) | 38 | -- | -- | (< 1%) 12.65K to 12.62K | |
| 14-Mar-16 9:41 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Mar-16 | Option Exercise | 19,309 | -- | -- | 480% 4.02K to 23.33K | |
| 08-Mar-16 4:43 PM View: | Bristol-Myers Squibb Co. (BMY) | 06-Mar-16 | Payment of Exercise | 1,125 | $64.71 | $72,798.80 | (29%) 3.83K to 2.71K | 14% |
| 08-Mar-16 4:43 PM View: | Bristol-Myers Squibb Co. (BMY) | 06-Mar-16 | Acquisition (other) | 1,220 | -- | -- | 92% 1.33K to 2.55K |